Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Helena Faust"'
Autor:
Penelope Gray, Hanna Kann, Ville N Pimenoff, Tiina Eriksson, Tapio Luostarinen, Simopekka Vänskä, Heljä-Marja Surcel, Helena Faust, Joakim Dillner, Matti Lehtinen
Publikováno v:
PLoS Medicine, Vol 18, Iss 6, p e1003588 (2021)
BackgroundCervical cancer elimination through human papillomavirus (HPV) vaccination programs requires the attainment of herd effect. Due to its uniquely high basic reproduction number, the vaccination coverage required to achieve herd effect against
Externí odkaz:
https://doaj.org/article/731dbd7731f44c9eb37d26d1a886688f
Autor:
Davit Bzhalava, Hanna Johansson, Johanna Ekström, Helena Faust, Birgitta Möller, Carina Eklund, Peter Nordin, Bo Stenquist, John Paoli, Bengt Persson, Ola Forslund, Joakim Dillner
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e65953 (2013)
To assess presence of virus DNA in skin lesions, swab samples from 82 squamous cell carcinomas of the skin (SCCs), 60 actinic keratoses (AKs), paraffin-embedded biopsies from 28 SCCs and 72 kerathoacanthomas (KAs) and fresh-frozen biopsies from 92 KA
Externí odkaz:
https://doaj.org/article/76e0035420574202a9fafd76e3bcc9f7
Publikováno v:
The Journal of Infectious Diseases. 223:1992-2000
Background Human papillomaviruses (HPV) cause several human cancers. Bivalent (Cervarix) and quadrivalent (qGardasil) HPV vaccines both contain virus-like particles of the major oncogenic HPV types 16 and 18, but also cross-protect against some nonva
Autor:
Philippe Mayaud, Matthew Chersich, Sinead Delany-Moretlwe, Admire Chikandiwa, Helena Faust, Joakim Dillner
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 84:141-148
Background Men living with HIV (MLHIV) have a high burden of human papillomavirus (HPV)-related cancer. Understanding serological dynamics of HPV in men can guide decisions on introducing HPV vaccination and monitoring impact. We determined HPV serop
Publikováno v:
The Journal of Infectious Diseases. 219:489-496
Background Antibodies against human papillomaviruses (HPVs) are biomarkers for current or past infections. We assessed whether antibodies against multiple HPV types were determinants of current multiple anogenital HPV infections, abnormal cytology, a
Autor:
Helena Faust, Tapio Luostarinen, Simopekka Vänskä, Joakim Dillner, Matti Lehtinen, Ville Pimenoff, Hanna Kann, Penelope Gray, Heljä Marja Surcel, Tiina Eriksson
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS Medicine, Vol 18, Iss 6, p e1003588 (2021)
PLoS Medicine
Universidad de Barcelona
PLoS Medicine, Vol 18, Iss 6, p e1003588 (2021)
PLoS Medicine
Background Cervical cancer elimination through human papillomavirus (HPV) vaccination programs requires the attainment of herd effect. Due to its uniquely high basic reproduction number, the vaccination coverage required to achieve herd effect agains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1ffaeda2168ff7d4d06a9e700d4846a
http://hdl.handle.net/2445/178983
http://hdl.handle.net/2445/178983
Autor:
Ville Pimenoff, Simopekka Vänskä, Matti Lehtinen, Joakim Dillner, Tiina Eriksson, Heljä-Marja Surcel, Helena Faust, Penelope Gray, Hanna Kann, Indira Adhikari
Publikováno v:
International journal of cancerREFERENCES. 147(12)
Large scale human papillomavirus (HPV) vaccination against the most oncogenic high-risk human papillomavirus (HPV) types 16/18 is rapidly reducing their incidence. However, attempts at assessing if this leads to an increase of nonvaccine targeted HPV
Publikováno v:
International journal of cancerReferences. 146(9)
Human papillomavirus (HPV) vaccines protect against infections with the most oncogenic HPV types, cervical intraepithelial neoplasia (CIN) and cervical cancer. We investigated whether development of cervical intraepithelial neoplasia (CIN) lesions in
Publikováno v:
The Journal of Infectious Diseases. 218:398-405
Background The antibody responses against human papillomavirus type 16 (HPV-16) and HPV-18 are well known, but many genital HPV types are oncogenic. We assessed the correlation between detection of type-specific HPV DNA and antibodies for 11 HPV type
Autor:
M. Zappa, Paolo Bonanni, Helena Faust, E. Paci, Francesca Carozzi, C. Ocello, Cristina Sani, Massimo Confortini, A. Iossa, Elena Burroni
Publikováno v:
Journal of Clinical Virology. 84:74-81
Background and objectives A randomized trial was conducted in Tuscany, Italy, to evaluate the effectiveness of HPV vaccination for 25 year old (yo) women who attend at the first time cervical cancer screening. The trial also evaluated immune response